 | • レポートコード：GIR201115835 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、体外肺の世界市場を調査対象にし、体外肺の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（2Dセルモデル、3Dセルモデル、商用3Dセルモデル、社内3Dセルモデル）、用途別分析（薬物スクリーニング、毒物学、3Dモデル開発、基礎研究、生理学的研究、幹細胞研究、再生医療）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：ATCC、Insphero、Mattek、Lonza、Tissuse、Epithelix、Mimetas、Emulate、Cn Bio ・企業別売上、市場シェア ・体外肺の地域別市場分析 ・体外肺の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・体外肺のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・体外肺のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・体外肺の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・体外肺の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・体外肺の種類別市場規模2015-2020：2Dセルモデル、3Dセルモデル、商用3Dセルモデル、社内3Dセルモデル ・体外肺の用途別市場規模2015-2020：薬物スクリーニング、毒物学、3Dモデル開発、基礎研究、生理学的研究、幹細胞研究、再生医療 ・体外肺の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論 |
Market Overview
The global Lungs in Vitro market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Lungs in Vitro market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Lungs in Vitro market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Lungs in Vitro market has been segmented into:
2D Cell Models
3D Cell Models
Commercial 3D Cell Models
Inhouse 3D Cell Models
By Application, Lungs in Vitro has been segmented into:
Drug Screening
Toxicology
3D Model Development
Basic Research
Physiologic Research
Stem Cell Research
Regenerative Medicine
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Lungs in Vitro market presented in the report. This section sheds light on the sales growth of different regional and country-level Lungs in Vitro markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Lungs in Vitro market.
The report offers in-depth assessment of the growth and other aspects of the Lungs in Vitro market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Lungs in Vitro Market Share Analysis
Lungs in Vitro competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Lungs in Vitro sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Lungs in Vitro sales, revenue and market share for each player covered in this report.
The major players covered in Lungs in Vitro are:
ATCC
Insphero
Mattek
Lonza
Tissuse
Epithelix
Mimetas
Emulate
Cn Bio
Table of Contents
1 Lungs in Vitro Market Overview
1.1 Product Overview and Scope of Lungs in Vitro
1.2 Classification of Lungs in Vitro by Type
1.2.1 Global Lungs in Vitro Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Lungs in Vitro Revenue Market Share by Type in 2019
1.2.3 2D Cell Models
1.2.4 3D Cell Models
1.2.5 Commercial 3D Cell Models
1.2.6 Inhouse 3D Cell Models
1.3 Global Lungs in Vitro Market by Application
1.3.1 Overview: Global Lungs in Vitro Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Drug Screening
1.3.3 Toxicology
1.3.4 3D Model Development
1.3.5 Basic Research
1.3.6 Physiologic Research
1.3.7 Stem Cell Research
1.3.8 Regenerative Medicine
1.4 Global Lungs in Vitro Market by Regions
1.4.1 Global Lungs in Vitro Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Lungs in Vitro (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Lungs in Vitro Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Lungs in Vitro Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Lungs in Vitro Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Lungs in Vitro Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Lungs in Vitro Status and Prospect (2015-2025)
2 Company Profiles
2.1 ATCC
2.1.1 ATCC Details
2.1.2 ATCC Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 ATCC SWOT Analysis
2.1.4 ATCC Product and Services
2.1.5 ATCC Lungs in Vitro Revenue, Gross Margin and Market Share (2018-2019)
2.2 Insphero
2.2.1 Insphero Details
2.2.2 Insphero Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Insphero SWOT Analysis
2.2.4 Insphero Product and Services
2.2.5 Insphero Lungs in Vitro Revenue, Gross Margin and Market Share (2018-2019)
2.3 Mattek
2.3.1 Mattek Details
2.3.2 Mattek Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Mattek SWOT Analysis
2.3.4 Mattek Product and Services
2.3.5 Mattek Lungs in Vitro Revenue, Gross Margin and Market Share (2018-2019)
2.4 Lonza
2.4.1 Lonza Details
2.4.2 Lonza Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Lonza SWOT Analysis
2.4.4 Lonza Product and Services
2.4.5 Lonza Lungs in Vitro Revenue, Gross Margin and Market Share (2018-2019)
2.5 Tissuse
2.5.1 Tissuse Details
2.5.2 Tissuse Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Tissuse SWOT Analysis
2.5.4 Tissuse Product and Services
2.5.5 Tissuse Lungs in Vitro Revenue, Gross Margin and Market Share (2018-2019)
2.6 Epithelix
2.6.1 Epithelix Details
2.6.2 Epithelix Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Epithelix SWOT Analysis
2.6.4 Epithelix Product and Services
2.6.5 Epithelix Lungs in Vitro Revenue, Gross Margin and Market Share (2018-2019)
2.7 Mimetas
2.7.1 Mimetas Details
2.7.2 Mimetas Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Mimetas SWOT Analysis
2.7.4 Mimetas Product and Services
2.7.5 Mimetas Lungs in Vitro Revenue, Gross Margin and Market Share (2018-2019)
2.8 Emulate
2.8.1 Emulate Details
2.8.2 Emulate Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Emulate SWOT Analysis
2.8.4 Emulate Product and Services
2.8.5 Emulate Lungs in Vitro Revenue, Gross Margin and Market Share (2018-2019)
2.9 Cn Bio
2.9.1 Cn Bio Details
2.9.2 Cn Bio Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Cn Bio SWOT Analysis
2.9.4 Cn Bio Product and Services
2.9.5 Cn Bio Lungs in Vitro Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Lungs in Vitro Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Lungs in Vitro Players Market Share
3.2.2 Top 10 Lungs in Vitro Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Lungs in Vitro Revenue and Market Share by Regions
4.2 North America Lungs in Vitro Revenue and Growth Rate (2015-2020)
4.3 Europe Lungs in Vitro Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Lungs in Vitro Revenue and Growth Rate (2015-2020)
4.5 South America Lungs in Vitro Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Lungs in Vitro Revenue and Growth Rate (2015-2020)
5 North America Lungs in Vitro Revenue by Countries
5.1 North America Lungs in Vitro Revenue by Countries (2015-2020)
5.2 USA Lungs in Vitro Revenue and Growth Rate (2015-2020)
5.3 Canada Lungs in Vitro Revenue and Growth Rate (2015-2020)
5.4 Mexico Lungs in Vitro Revenue and Growth Rate (2015-2020)
6 Europe Lungs in Vitro Revenue by Countries
6.1 Europe Lungs in Vitro Revenue by Countries (2015-2020)
6.2 Germany Lungs in Vitro Revenue and Growth Rate (2015-2020)
6.3 UK Lungs in Vitro Revenue and Growth Rate (2015-2020)
6.4 France Lungs in Vitro Revenue and Growth Rate (2015-2020)
6.5 Russia Lungs in Vitro Revenue and Growth Rate (2015-2020)
6.6 Italy Lungs in Vitro Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Lungs in Vitro Revenue by Countries
7.1 Asia-Pacific Lungs in Vitro Revenue by Countries (2015-2020)
7.2 China Lungs in Vitro Revenue and Growth Rate (2015-2020)
7.3 Japan Lungs in Vitro Revenue and Growth Rate (2015-2020)
7.4 Korea Lungs in Vitro Revenue and Growth Rate (2015-2020)
7.5 India Lungs in Vitro Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Lungs in Vitro Revenue and Growth Rate (2015-2020)
8 South America Lungs in Vitro Revenue by Countries
8.1 South America Lungs in Vitro Revenue by Countries (2015-2020)
8.2 Brazil Lungs in Vitro Revenue and Growth Rate (2015-2020)
8.3 Argentina Lungs in Vitro Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Lungs in Vitro by Countries
9.1 Middle East & Africa Lungs in Vitro Revenue by Countries (2015-2020)
9.2 Saudi Arabia Lungs in Vitro Revenue and Growth Rate (2015-2020)
9.3 UAE Lungs in Vitro Revenue and Growth Rate (2015-2020)
9.4 Egypt Lungs in Vitro Revenue and Growth Rate (2015-2020)
9.5 South Africa Lungs in Vitro Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Lungs in Vitro Revenue and Market Share by Type (2015-2020)
10.2 Global Lungs in Vitro Market Forecast by Type (2019-2024)
10.3 2D Cell Models Revenue Growth Rate (2015-2025)
10.4 3D Cell Models Revenue Growth Rate (2015-2025)
10.5 Commercial 3D Cell Models Revenue Growth Rate (2015-2025)
10.6 Inhouse 3D Cell Models Revenue Growth Rate (2015-2025)
11 Global Lungs in Vitro Market Segment by Application
11.1 Global Lungs in Vitro Revenue Market Share by Application (2015-2020)
11.2 Lungs in Vitro Market Forecast by Application (2019-2024)
11.3 Drug Screening Revenue Growth (2015-2020)
11.4 Toxicology Revenue Growth (2015-2020)
11.5 3D Model Development Revenue Growth (2015-2020)
11.6 Basic Research Revenue Growth (2015-2020)
11.7 Physiologic Research Revenue Growth (2015-2020)
11.8 Stem Cell Research Revenue Growth (2015-2020)
11.9 Regenerative Medicine Revenue Growth (2015-2020)
12 Global Lungs in Vitro Market Size Forecast (2021-2025)
12.1 Global Lungs in Vitro Market Size Forecast (2021-2025)
12.2 Global Lungs in Vitro Market Forecast by Regions (2021-2025)
12.3 North America Lungs in Vitro Revenue Market Forecast (2021-2025)
12.4 Europe Lungs in Vitro Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Lungs in Vitro Revenue Market Forecast (2021-2025)
12.6 South America Lungs in Vitro Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Lungs in Vitro Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Lungs in Vitro Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Lungs in Vitro by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Lungs in Vitro Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Lungs in Vitro Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. ATCC Corporate Information, Location and Competitors
Table 6. ATCC Lungs in Vitro Major Business
Table 7. ATCC Lungs in Vitro Total Revenue (USD Million) (2017-2018)
Table 8. ATCC SWOT Analysis
Table 9. ATCC Lungs in Vitro Product and Solutions
Table 10. ATCC Lungs in Vitro Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Insphero Corporate Information, Location and Competitors
Table 12. Insphero Lungs in Vitro Major Business
Table 13. Insphero Lungs in Vitro Total Revenue (USD Million) (2018-2019)
Table 14. Insphero SWOT Analysis
Table 15. Insphero Lungs in Vitro Product and Solutions
Table 16. Insphero Lungs in Vitro Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Mattek Corporate Information, Location and Competitors
Table 18. Mattek Lungs in Vitro Major Business
Table 19. Mattek Lungs in Vitro Total Revenue (USD Million) (2017-2018)
Table 20. Mattek SWOT Analysis
Table 21. Mattek Lungs in Vitro Product and Solutions
Table 22. Mattek Lungs in Vitro Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Lonza Corporate Information, Location and Competitors
Table 24. Lonza Lungs in Vitro Major Business
Table 25. Lonza Lungs in Vitro Total Revenue (USD Million) (2017-2018)
Table 26. Lonza SWOT Analysis
Table 27. Lonza Lungs in Vitro Product and Solutions
Table 28. Lonza Lungs in Vitro Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Tissuse Corporate Information, Location and Competitors
Table 30. Tissuse Lungs in Vitro Major Business
Table 31. Tissuse Lungs in Vitro Total Revenue (USD Million) (2017-2018)
Table 32. Tissuse SWOT Analysis
Table 33. Tissuse Lungs in Vitro Product and Solutions
Table 34. Tissuse Lungs in Vitro Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Epithelix Corporate Information, Location and Competitors
Table 36. Epithelix Lungs in Vitro Major Business
Table 37. Epithelix Lungs in Vitro Total Revenue (USD Million) (2017-2018)
Table 38. Epithelix SWOT Analysis
Table 39. Epithelix Lungs in Vitro Product and Solutions
Table 40. Epithelix Lungs in Vitro Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Mimetas Corporate Information, Location and Competitors
Table 42. Mimetas Lungs in Vitro Major Business
Table 43. Mimetas Lungs in Vitro Total Revenue (USD Million) (2017-2018)
Table 44. Mimetas SWOT Analysis
Table 45. Mimetas Lungs in Vitro Product and Solutions
Table 46. Mimetas Lungs in Vitro Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Emulate Corporate Information, Location and Competitors
Table 48. Emulate Lungs in Vitro Major Business
Table 49. Emulate Lungs in Vitro Total Revenue (USD Million) (2017-2018)
Table 50. Emulate SWOT Analysis
Table 51. Emulate Lungs in Vitro Product and Solutions
Table 52. Emulate Lungs in Vitro Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Cn Bio Corporate Information, Location and Competitors
Table 54. Cn Bio Lungs in Vitro Major Business
Table 55. Cn Bio Lungs in Vitro Total Revenue (USD Million) (2017-2018)
Table 56. Cn Bio SWOT Analysis
Table 57. Cn Bio Lungs in Vitro Product and Solutions
Table 58. Cn Bio Lungs in Vitro Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Global Lungs in Vitro Revenue (Million USD) by Players (2015-2020)
Table 60. Global Lungs in Vitro Revenue Share by Players (2015-2020)
Table 61. Global Lungs in Vitro Revenue (Million USD) by Regions (2015-2020)
Table 62. Global Lungs in Vitro Revenue Market Share by Regions (2015-2020)
Table 63. North America Lungs in Vitro Revenue by Countries (2015-2020)
Table 64. North America Lungs in Vitro Revenue Market Share by Countries (2015-2020)
Table 65. Europe Lungs in Vitro Revenue (Million USD) by Countries (2015-2020)
Table 66. Asia-Pacific Lungs in Vitro Revenue (Million USD) by Countries (2015-2020)
Table 67. South America Lungs in Vitro Revenue by Countries (2015-2020)
Table 68. South America Lungs in Vitro Revenue Market Share by Countries (2015-2020)
Table 69. Middle East and Africa Lungs in Vitro Revenue (Million USD) by Countries (2015-2020)
Table 70. Middle East and Africa Lungs in Vitro Revenue Market Share by Countries (2015-2020)
Table 71. Global Lungs in Vitro Revenue (Million USD) by Type (2015-2020)
Table 72. Global Lungs in Vitro Revenue Share by Type (2015-2020)
Table 73. Global Lungs in Vitro Revenue Forecast by Type (2021-2025)
Table 74. Global Lungs in Vitro Revenue by Application (2015-2020)
Table 75. Global Lungs in Vitro Revenue Share by Application (2015-2020)
Table 76. Global Lungs in Vitro Revenue Forecast by Application (2021-2025)
Table 77. Global Lungs in Vitro Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Lungs in Vitro Picture
Figure 2. Global Lungs in Vitro Revenue Market Share by Type in 2019
Figure 3. 2D Cell Models Picture
Figure 4. 3D Cell Models Picture
Figure 5. Commercial 3D Cell Models Picture
Figure 6. Inhouse 3D Cell Models Picture
Figure 7. Lungs in Vitro Revenue Market Share by Application in 2019
Figure 8. Drug Screening Picture
Figure 9. Toxicology Picture
Figure 10. 3D Model Development Picture
Figure 11. Basic Research Picture
Figure 12. Physiologic Research Picture
Figure 13. Stem Cell Research Picture
Figure 14. Regenerative Medicine Picture
Figure 15. Global Lungs in Vitro Revenue (USD Million) and Growth Rate (2015-2025)
Figure 16. North America Lungs in Vitro Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Europe Lungs in Vitro Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Asia-Pacific Lungs in Vitro Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. South America Lungs in Vitro Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Middle East and Africa Lungs in Vitro Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Global Lungs in Vitro Revenue (Million USD) and Growth Rate (2015-2025)
Figure 22. Global Lungs in Vitro Revenue Share by Players in 2019
Figure 23. Global Top 5 Players Lungs in Vitro Revenue Market Share in 2019
Figure 24. Global Top 10 Players Lungs in Vitro Revenue Market Share in 2019
Figure 25. Key Players Market Share Trend
Figure 26. Global Lungs in Vitro Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 27. Global Lungs in Vitro Revenue Market Share by Regions (2015-2020)
Figure 28. Global Lungs in Vitro Revenue Market Share by Regions in 2018
Figure 29. North America Lungs in Vitro Revenue and Growth Rate (2015-2020)
Figure 30. Europe Lungs in Vitro Revenue and Growth Rate (2015-2020)
Figure 31. Asia-Pacific Lungs in Vitro Revenue and Growth Rate (2015-2020)
Figure 32. South America Lungs in Vitro Revenue and Growth Rate (2015-2020)
Figure 33. Middle East and Africa Lungs in Vitro Revenue and Growth Rate (2015-2020)
Figure 34. North America Lungs in Vitro Revenue Market Share by Countries (2015-2020)
Figure 35. North America Lungs in Vitro Revenue Market Share by Countries in 2019
Figure 36. USA Lungs in Vitro Revenue and Growth Rate (2015-2020)
Figure 37. Canada Lungs in Vitro Revenue and Growth Rate (2015-2020)
Figure 38. Mexico Lungs in Vitro Revenue and Growth Rate (2015-2020)
Figure 39. Europe Lungs in Vitro Revenue Market Share by Countries (2015-2020)
Figure 40. Europe Lungs in Vitro Revenue Market Share by Countries in 2019
Figure 41. Germany Lungs in Vitro Revenue and Growth Rate (2015-2020)
Figure 42. UK Lungs in Vitro Revenue and Growth Rate (2015-2020)
Figure 43. France Lungs in Vitro Revenue and Growth Rate (2015-2020)
Figure 44. Russia Lungs in Vitro Revenue and Growth Rate (2015-2020)
Figure 45. Italy Lungs in Vitro Revenue and Growth Rate (2015-2020)
Figure 46. Asia-Pacific Lungs in Vitro Revenue Market Share by Countries (2015-2020)
Figure 47. Asia-Pacific Lungs in Vitro Revenue Market Share by Countries in 2019
Figure 48. China Lungs in Vitro Revenue and Growth Rate (2015-2020)
Figure 49. Japan Lungs in Vitro Revenue and Growth Rate (2015-2020)
Figure 50. Korea Lungs in Vitro Revenue and Growth Rate (2015-2020)
Figure 51. India Lungs in Vitro Revenue and Growth Rate (2015-2020)
Figure 52. Southeast Asia Lungs in Vitro Revenue and Growth Rate (2015-2020)
Figure 53. South America Lungs in Vitro Revenue Market Share by Countries (2015-2020)
Figure 54. South America Lungs in Vitro Revenue Market Share by Countries in 2019
Figure 55. Brazil Lungs in Vitro Revenue and Growth Rate (2015-2020)
Figure 56. Argentina Lungs in Vitro Revenue and Growth Rate (2015-2020)
Figure 57. Middle East and Africa Lungs in Vitro Revenue Market Share by Countries (2015-2020)
Figure 58. Middle East and Africa Lungs in Vitro Revenue Market Share by Countries in 2019
Figure 59. Saudi Arabia Lungs in Vitro Revenue and Growth Rate (2015-2020)
Figure 60. UAE Lungs in Vitro Revenue and Growth Rate (2015-2020)
Figure 61. Egypt Lungs in Vitro Revenue and Growth Rate (2015-2020)
Figure 62. South Africa Lungs in Vitro Revenue and Growth Rate (2015-2020)
Figure 63. Global Lungs in Vitro Revenue Share by Type (2015-2020)
Figure 64. Global Lungs in Vitro Revenue Share by Type in 2019
Figure 65. Global Lungs in Vitro Market Share Forecast by Type (2021-2025)
Figure 66. Global 2D Cell Models Revenue Growth Rate (2015-2020)
Figure 67. Global 3D Cell Models Revenue Growth Rate (2015-2020)
Figure 68. Global Commercial 3D Cell Models Revenue Growth Rate (2015-2020)
Figure 69. Global Inhouse 3D Cell Models Revenue Growth Rate (2015-2020)
Figure 70. Global Lungs in Vitro Revenue Share by Application (2015-2020)
Figure 71. Global Lungs in Vitro Revenue Share by Application in 2019
Figure 72. Global Lungs in Vitro Market Share Forecast by Application (2021-2025)
Figure 73. Global Drug Screening Revenue Growth Rate (2015-2020)
Figure 74. Global Toxicology Revenue Growth Rate (2015-2020)
Figure 75. Global 3D Model Development Revenue Growth Rate (2015-2020)
Figure 76. Global Basic Research Revenue Growth Rate (2015-2020)
Figure 77. Global Physiologic Research Revenue Growth Rate (2015-2020)
Figure 78. Global Stem Cell Research Revenue Growth Rate (2015-2020)
Figure 79. Global Regenerative Medicine Revenue Growth Rate (2015-2020)
Figure 80. Global Lungs in Vitro Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 81. Global Lungs in Vitro Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 82. Global Lungs in Vitro Revenue Market Share Forecast by Regions (2021-2025)
Figure 83. North America Lungs in Vitro Revenue Market Forecast (2021-2025)
Figure 84. Europe Lungs in Vitro Revenue Market Forecast (2021-2025)
Figure 85. Asia-Pacific Lungs in Vitro Revenue Market Forecast (2021-2025)
Figure 86. South America Lungs in Vitro Revenue Market Forecast (2021-2025)
Figure 87. Middle East and Africa Lungs in Vitro Revenue Market Forecast (2021-2025)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
体外診断システムの世界市場 2020年 Market Overview The global In Vitro Diagnostics Systems market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The In Vitro Diagnos…- 体外大腸がんスクリーニング検査の世界市場 2020年 Market Overview The global In-Vitro Colorectal Cancer Screening Tests market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.3% in the forecast period of 2020 to 2025 and will expected to reach USD 1185 million by 2025, from USD 964.8 million in 2019. …
- 体外診断の世界市場 2020年 Market Overview The In-Vitro Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …
- 細胞ベースヒト化マウスモデルの世界市場 2020年 Market Overview The global Cell-based Humanized Mouse Models market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Cell-based …
- 手術用3Dプリントモデルの世界市場 2020年 Market Overview The global 3D Printed Surgical Models market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The 3D Printed Surgica…